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ABSTRACT
The exosome complex is a major eukaryotic exori-
bonuclease that requires the SKI complex for its
activity in the cytoplasm. In yeast, the Ski7 protein
links both complexes, whereas a functional equiva-
lent of the Ski7 has remained unknown in the human
genome.
Proteomic analysis revealed that a previously
uncharacterized short splicing isoform of HBS1L
(HBS1LV3) is the long-sought factor linking the
exosome and SKI complexes in humans. In con-
trast, the canonical HBS1L variant, HBS1LV1, which
acts as a ribosome dissociation factor, does not
associate with the exosome and instead interacts
with the mRNA surveillance factor PELOTA. Inter-
estingly, both HBS1LV1 and HBS1LV3 interact with
the SKI complex and HBS1LV1 seems to antagonize
SKI/exosome supercomplex formation. HBS1LV3
contains a unique C-terminal region of unknown
structure, with a conserved RxxxFxxxL motif respon-
sible for exosome binding and may interact with the
exosome core subunit RRP43 in a way that resembles
the association between Rrp6 RNase and Rrp43 in
yeast. HBS1LV3 or the SKI complex helicase (SKI2W)
depletion similarly affected the transcriptome, dereg-
ulating multiple genes. Furthermore, half-lives of
representative upregulated mRNAs were increased,
supporting the involvement of HBS1LV3 and SKI2W
in the same mRNA degradation pathway, essential
for transcriptome homeostasis in the cytoplasm.
INTRODUCTION
Messenger RNA (mRNA) molecules exist largely to pro-
duce proteins. Since steady-state mRNA levels are deter-
mined by the rates of synthesis and decay, cytoplasmic
degradation of mRNA plays a fundamental role in the reg-
ulation of gene expression.
Multiple enzymes, particularly nucleases, participate in
eukaryotic mRNA decay. Nucleases involved in 3′-5′ cyto-
plasmic mRNA degradation pathways can act individually
(e.g. the DIS3L2 protein) (1,2), or be constituents of mul-
tisubunit complexes. The exosome is a major multisubunit
nuclease that catalyzes the 3′-5′ degradation ofRNA in both
the nucleus and the cytoplasm (3,4).
The exosome comprises a nine-subunit, ring-shaped, cat-
alytically inactive core that associates with one (EXOSC10
[RRP6] or DIS3 or DIS3L) or two (EXOSC10 and DIS3)
3′-5′ exoribonucleases (5,6). Several functional isoforms of
the exosome are found in human cells (7) – each has distinct
catalytic subunits and occupies a different intracellular lo-
cation. The 10-subunit isoform encompassing the ring and
only one nuclease – the EXOSC10 protein – is localized in
the nucleoli. Meanwhile, the 11-subunit exosome complex
has a nucleoplasmic localization and consists of the ring,
EXOSC10 and an additional nuclease, DIS3. However, a
small fraction of complexes associated with DIS3 and EX-
OSC10 proteins can also be found in the cytoplasm. The
main cytoplasmic isoform containing a DIS3 paralogue,
the DIS3-like protein (DIS3L), participates in 3′-5′ mRNA
degradation in the cytoplasmic compartment (1,5).
The substrates of exosome complexes containing DIS3L
or DIS3 pass through the central channel of the exo-
some ring to reach the exoribonuclease active site (8–12).
Although the exosome complex efficiently degrades both
single-stranded and partially double-stranded RNA sub-
strates in vitro, studies in yeast showed that cooperation
between the exosome and the SKI complex is indispens-
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able for efficient cytoplasmic mRNA decay in vivo (13–15).
The yeast SKI complex was initially identified as being es-
sential for degradation of virus-like particles (16) and was
since characterized as a hetero-tetramer composed of Ski2,
Ski3 and two copies of the Ski8 protein. Through its heli-
case activity, Ski2 is the catalytic subunit of the SKI com-
plex and forms part of the structure that contains the cen-
tral channel. Ski3 and Ski8 are RNA-binding proteins that
have regulatory functions (17). RNA substrates are deliv-
ered through the SKI complex structure directly to the cen-
tral channel of the exosome ring (17).
Our current knowledge about the SKI complex in hu-
mans is very limited. The human orthologues of yeast SKI2,
SKI3 and SKI8 genes are SKIV2L, TTC37 and WDR61,
respectively (18). Mutations in TTC37 and SKIV2L cause
the extremely rare congenital bowel disorder known as tri-
chohepatoenteric syndrome (19,20). Moreover, the product
of the SKIV2L gene (the SKI2W protein) is an important
contributor to the regulation of the innate immune response
that detects foreign nucleic acids (21). Despite the associ-
ation between the SKI complex and genetic diseases, the
exosome/SKI-dependent RNA decay pathways and RNA
substrates that are targeted by this supercomplex have not
been extensively studied in human cells. In particular, little
is known about the mechanism that ensures the physical in-
teraction between the human SKI and exosome complexes.
The yeast SKI complex interacts with the exosome via
the auxiliary Ski7 protein, which is an integral component
of the cytoplasmic exosome isoform (14,22,23). The phe-
notype of SKI7 deletion mutants is indistinguishable from
that resulting from deletion of genes encoding SKI complex
subunits, and leads to inactivation of cytoplasmic exosome-
dependent mRNA turnover and quality control pathways
as well as to elevated copy numbers of yeast virus-like par-
ticles (13,16,24,25). Yeast Ski7 contains domains that share
homology with the Hbs1, a GTPase that interacts with
Dom34 (PELOTA in humans). This two-subunit complex,
structurally similar to eRF3-eRF1, is responsible for disso-
ciation of stalled ribosomes (26). Hbs1 is also a ribosomal
surveillance factor, involved in no-go and non-stop mRNA
decay (26,27). Due to structural differences between the N-
terminal regions of yeast Ski7 and Hbs1 proteins, only Ski7
interacts with the exosome core (14), whereas Hbs1 partic-
ipates in translation-dependent RNA quality control path-
ways in Saccharomyces cerevisiae (28).
Since it was thought that no apparent orthologue of
the yeast Ski7 protein is encoded in the human genome,
the mechanism of cooperation between the SKI and exo-
some complexes in human cells remained unclear. Here, we
show that a protein encoded by a short splicing isoform of
HBS1L that contains a specific new region links the SKI
complex with the exosome, thus functioning as a Ski7 ana-
logue in humans.
MATERIALS AND METHODS
Cell culture
HEK293 Flp-In T-REx and derived stable cell lines were
grown in cell culture dishes in Dulbecco’s modified Ea-
gle’s medium (Gibco) supplemented with 10% fetal bovine
serum (Gibco) at 37◦C in a humidified 5%CO2 atmosphere.
Generation of stable cell lines
Stable inducible cell lines producing proteins of interest
were obtained using the Flp-In T-REx system (Invitrogen)
according to the manufacturer’s instructions.
siRNA transfection
siRNA-mediated knockdowns were performed using
siRNA (Eurogentec) and Lipofectamine RNAiMAX
Reagent (Invitrogen) according to the manufacturer’s
instructions. Test and negative control siRNA molecules
were used at a final concentration of 25 nM. To induce
production of exogenous protein variants, cells were grown
in the presence of doxycycline for an additional 48 h before
harvesting.
The siRNA sequences that specifically target endoge-
nousHBS1L,HBS1LV3 and SKIV2LmRNAare listed be-
low. siRNA oligonucleotide sequences against HBS1LV1,
SKIV2L and scrambled siRNA were described previously
(29,30). siRNA oligonucleotides against HBS1LV3 were
designed by Eurogentec.
siRNAs:
HBS1LV1 siRNA 5′-r(CCAGUAGAUUCCCAGACAU)d(TT)-3′
#1 SKIV2L siRNA 5′-r(GGAGAUAGACUUUGAGAAA)d(TT)-3′
#2 SKIV2L siRNA 5′-r(GCCUUAGCUGUAUGUUGGA)d(TT)-3′
#1 HBS1LV3 siRNA 5′-r(CCUGUCACAAUUAGCAAAU)d(TT)-3′
#2 HBS1LV3 siRNA 5′-r(GUCAUUGGCAUUUCAUAAA)d(TT)-3′
#3 HBS1LV3 siRNA 5′-r(GGCAUUUCAUAAAGCUUCU)d(TT)-3′
scrambled siRNA 5′-r(UUCUUCGAACGUGUCACGU)d(TT)-3′
We established HBS1LV1 siRNA, #2 SKIV2L siRNA
and #3HBS1LV3 siRNA as the most effective, and we used
them in all consecutive experiments shown in this study.
Transient transfection with plasmid vectors, cross-linking and
co-immunoprecipitation (Co-IP) assay
For transient transfection, HEK293 Flp-In T-REx cell lines
were cultured as previously described and transfected us-
ing TransIT-2020 reagent (Mirus) according to the manu-
facturer’s instructions. Cross-linking was performed using
dithiobis[succinimidyl propionate] (DSP; final conc. 2 mM)
(Pierce) according to themanufacturer’s protocol. Immuno-
precipitation was based on a previously described method
(31) with modifications:
Expression of exogenous genes was induced simultane-
ously with transient transfection by the addition of tetra-
cycline at a final concentration of 0.1 g/ml. Following
a 48 h incubation, cells were scraped off the plates and
pelleted at 400 × g for 3 min. Pellets were resuspended
in 0.7 ml lysis buffer (100 mM NaCl; 20 mM HEPES-
KOH pH = 7.1; 3 mM MgCl2; 1 mM PMSF; 20 nM pep-
statin; 6 nM leupeptin; 2 ng/ml chymostatin; 10% glyc-
erol; 0.5% NP-40) and incubated for 30 min at 4◦C in
the presence of 0.1 mg/ml RNase A (Sigma-Aldrich).
Lysates were then sonicated at 4◦C in a BioRuptor soni-
cator (Diagenode) using 25 pulses of 25 s at setting H (in-
terrupted by 25 s pauses) and centrifuged at 15 000 × g
for 15 min at 4◦C. Cleared extracts were mixed with 50–
100l aliquots of magnetic beads (CNBr-activated SepFast
Mag4F; Biotoolomics) coated with GFP-trap nanobodies
 at A
BE M
arketing on January 9, 2017
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Nucleic Acids Research, 2016 3
(home-made) (32) freshly washed with lysis buffer and in-
cubated for 1.5 h at 4◦C with rotation. Immunoprecipita-
tion was followed by five washes with washing buffer (0.5
M or 0.1 M NaCl; 20 mM HEPES-KOH pH = 7.1; 3 mM
MgCl2; 1 mM PMSF; 20 nM pepstatin; 6 nM leupeptin;
2 ng/ml chymostatin; 10% glycerol; 0.5% NP-40) and one
wash with lysis buffer (see above). Two methods of protein
complex elution and analysis were used: (i) Protein com-
plexes were eluted for 5 min at 95◦C in sodium dodecyl-
sulphate (SDS) sample buffer (64 mM Tris-HCl pH = 6.8;
15% 2-mercaptoethanol; 10% glycerol; 2% SDS; 0.1% bro-
mophenol blue) and then analyzed by SDS-PAGE followed
by Western blot analysis, or (ii) Protein complexes were
eluted for 10 min at 95◦C in stripping buffer (50 mM Tris-
HCl pH 8.0; 50 mM DTT; 1 mM PMSF; 20 nM pepstatin;
6 nM leupeptin; 2 ng/ml chymostatin; 10% glycerol, 3%
SDS), precipitated using a standard chloroform–methanol
protocol (33) and analyzed by High Resolution Mass Spec-
trometry.
Mass spectrometry analysis
Precipitated proteins were dissolved in 100 l of 100 mM
ammonium bicarbonate buffer, reduced in 100 mM DTT
for 30 min at 57◦C, alkylated in 55 mM iodoacetamide for
40 min at RT in the dark and digested overnight with 10
ng/ml trypsin (Promega) at 37◦C. Finally, trifluoroacetic
acidwas added at a final concentration of 0.1%.MSanalysis
was performed by LC-MS in the Laboratory of Mass Spec-
trometry (IBB PAS, Warsaw) using a nanoAcquity UPLC
system (Waters) coupled to a LTQ-Orbitrap Velos mass
spectrometer (Thermo Scientific). Peptides were separated
by a 180min linear gradient of 95% solutionA (0.1% formic
acid in water) to 35% solution B (acetonitrile and 0.1%
formic acid). The measurement of each sample was pre-
ceded by three washing runs to avoid cross-contamination.
The final MS washing run was searched for the presence
of cross-contamination between samples. If the protein of
interest was identified in the washing run and in the next
measured sample at the same or smaller intensity, then the
sample was treated as cross-contamination. These samples
were excluded from final graphs.
The mass spectrometer was operated in the data-
dependent MS-MS2 mode, and data were acquired in the
m/z range of 300–2000. Data were analyzed with the Max-
Quant (Version 1.5.3.12) platform. The reference human
proteome database from UniProt was used, and HBS1L
protein sequences were removed and replaced with unique
sequence fragments of HBS1LV1 and HBS1LV3. Label-
Free-Quantification (LFQ) intensity values were calculated
using the MaxLFQ algorithm. Identified proteins were an-
alyzed as follows. Protein abundance was defined as the sig-
nal intensity calculated byMaxQuant software for a protein
(sumof intensities of identified peptides of given protein) di-
vided by its molecular weight. Specificity was defined as the
ratio of the protein LFQ intensity measured in the bait pu-
rification to background level (i.e. protein LFQ intensity in
the negative control purification with the background level
arbitrarily set to 1 for proteins not detected in the negative
control). High values of both protein abundance and speci-
ficity indicated proteins that were enriched in the purifica-
tion, and thus suggested interactions. The exosome, the SKI
complex components and HBS1L proteins are included in
the Figure 1A, B, E, F and Supplementary Figure S1. Ex-
tended data are presented in the Supplementary Figure S2.
Since the HBS1LV1 protein was identified in a washing run
before theHBS1LV3 co-immunoprecipitation (Co-IP)mea-
surement, the HBS1LV1 hit was deemed an artefact and as
such was removed from Figure 1E.
Real-Time quantitative PCR (qPCR) validation
RNA for quantitative PCR (qPCR) was isolated from
HEK293 Flp-In T-REx cell lines induced with doxycycline
(0.1 g/ml), using TRI Reagent (Sigma-Aldrich) accord-
ing to themanufacturer’s instructions. To eliminate genomic
DNA, 10 g of total RNA was treated with 4U TURBO
DNase (Ambion) and incubated at 37◦C for 2 h. RNA was
then extracted using phenol:chloroform and precipitated
with isopropanol. cDNA synthesis was performed using 2
g of DNase-treated RNA, 250 ng random hexamers, 50
pmol oligo(dT) primer and 200 U SuperScript III Reverse
Transcriptase (Life Technologies). qPCR reactions were
performed according to the manufacturer’s guidelines us-
ing 20 ng of the cDNAand aRoche LightCycler 480 system.
Analyses were performed in triplicate. Reactionswithout re-
verse transcriptase (negative controls) were also carried out
and showed an insignificant background. The specificity of
each reaction was confirmed by a melting curve analysis.
GAPDH mRNA was used for normalization. XIST and
MALAT1 long non-coding RNAs were used for RNAi nor-
malization because RNA-seq data showed that their levels
were unaffected by HBS1LV3 depletion.
Bioinformatic analysis
Ribo-depleted total RNA was used to prepare strand-
specific libraries (dUTP RNA) that were subsequently pro-
cessed using an Illumina HiSeq sequencing platform in
the 75-nt pair-end mode. Experiments were performed in
triplicate and reads were mapped to the reference human
genome (hg38) using the STAR short read aligner (version
STAR 2.4.0b) (34). Quality control, read processing and fil-
tering, visualization of the results and counting of reads
for the Genecode v22 comprehensive annotation were per-
formed using custom scripts and elements of the RSeQC,
BEDtools and SAMtools packages. Differential expression
analyses were performed using the DESeq2 Bioconductor
R package (35).
Localization studies
Stable cell lines expressing EGFP-tagged HBS1LV1,
HBS1LV3 or SKI2W were cultured on Lab-Tek II Cham-
ber Slides (Thermo Scientific) coated with poly-L-lysine
(Sigma-Aldrich), for 24 h in the presence of tetracycline
(0.1 g/ml). Cells were incubated with nucleic acid stain
Hoechst 33342 (Invitrogen) at a final concentration of 1
g/ml for 30 min, then washed two times with phosphate
buffered saline (PBS) and fixed with 3.7% formaldehyde
for 30 min at room temperature. Cells were gently washed
three times with PBS and then mounted in ProLong Gold
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Figure 1. The cytoplasmic exosome complex interacts with HBS1LV3
but not HBS1LV1 in human cells. Semi-quantitative analysis of co-
antifade reagent (Invitrogen). Laser scanning confocal
microscopy imaging was performed on a FV1000 confocal
system (Olympus) with a 60x/1.4 oil immersion objective.
Co-sedimentation assay
Cell pellets were resuspended in 0.5 ml lysis buffer (50 mM
NaCl; 20mMHEPES-KOHpH= 7.1; 3mMMgCl2; 1mM
PMSF; 20 nM pepstatin; 6 nM leupeptin; 2 ng/ml chymo-
statin; 5%glycerol; 0.5%NP-40) and incubated for 30min at
4◦C in the presence of 0.1mg/mlRNaseA (Sigma-Aldrich).
Lysates were then sonicated at 4◦C in a BioRuptor sonica-
tor (Diagenode) using 25 pulses of 25 s at setting H (with
25 s intervals), and centrifuged at 15 000 × g for 15 min
at 4◦C. Cleared extracts were loaded onto 13 ml continu-
ous 10–30% glycerol gradients containing 50 mMNaCl, 20
mM HEPES-KOH pH = 7.1, 3 mMMgCl2, 1 mM PMSF,
20 nM pepstatin, 6 nM leupeptin, 2 ng/ml chymostatin and
centrifuged at 274 000 × g for 18 h at 4◦C; fractions were
collected using an A¨KTA FPLC machine. Collected frac-
tions were precipitated with trichloroacetic acid (final con-
centration 10%) overnight. Samples were then centrifuged
at 15 000 × g for 15 min at 4◦C, washed with 1 ml of cold
acetone and centrifuged again under the same conditions.
Proteins were resuspended in SDS sample buffer (64 mM
Tris-HCl pH = 6.8, 15% 2-mercaptoethanol, 10% glycerol,
2% SDS, 0.1% bromophenol blue) and used for Western
blotting analysis.
Structural analysis
HBS1LV3 helix models were created and visualized using
Coot (36) and PyMOL (The PyMOL Molecular Graph-
ics System, Schro¨dinger, LLC). Initial rigid-body docking
was performed using the ZDOCK server (37) in an unbi-
ased way (i.e. without selection of blocking and contacting
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
immunoprecipitation-mass spectrometry (Co-IP-MS) experiments using
EGFP-tagged (A) DIS3L, (B) RRP4, (E) HBS1LV3 or (F) HBS1LV1 pro-
teins as baits under high salt washing buffer conditions. Plots present the
exosome and SKI complex subunits identified in Co-IP-MS experiments
while other interactors are listed in Data set S1 and visualized in Supple-
mentary Figure S2. DSP cross-linker was used in experiments (A) and (B)
at the final concentration of 2 mM. The exosome core components are col-
ored grey. Estimated quantities of identified proteins were calculated using
the Label Free Quantification (LFQ) algorithm and are represented graph-
ically. Protein abundance was calculated as LFQ intensity of the protein
signal divided by its molecular weight and is shown on the x-axis in a log-
arithmic scale (log10). Specificity was defined as the ratio of protein LFQ
intensitymeasured in the bait Co-IP to the level of the background (protein
LFQ intensity in HEK293 T-REx sample), and shown on the y-axis in a
logarithmic scale. (C) Western blot showing HBS1LV1 andHBS1LV3 pro-
teins in HEK293 cells. siRNA-mediated protein depletion confirms spe-
cific HBS1L isoforms. siRNAs specific to HBS1LV1 or HBS1LV3 were
used. Proteins were analyzed using antibodies against the N-terminus of
the HBS1L and -GAPDH antibodies (loading control). Positions of the
HBS1LV1 andHBS1LV3 proteins are indicated. (D) Schematic representa-
tion of the domain architecture of eRF3, Ski7 and Hbs1 from S. cerevisiae
and humanHBS1L isoforms. Protein regions sharing similar functions are
shown in the same color. Two independent regions within the N-terminal
fragment of Ski7, shown in orange, are known to interact with the exosome
and the SKI complex. TheN-domains of eRF3 andHbs1 are coloredwhite
and grey, respectively. The GTPase domain is shown in blue. Domains II
and III of the eRF3-like domain are colored red and green, respectively.
The C-terminal fragment of HBS1LV3 is colored yellow.
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residues). For homology modeling, available structures of
S. cerevisiae Rrp43 in complex with Rrp6 were used (PDB
codes: 4IFD, 4OO1, 5C0W, 5C0X) (9,38). In this study we
also used the human exosome structure (PDB code: 2NN6)
(39).
Western blot analysis
Samples were processed using -HBS1L (1:2000;
HPA029729; Sigma-Aldrich), -EXOSC3 (1:3000; 15062-
1-AP; Proteintech Europe), -SKI2W (1:600; 11462-1-AP;
Proteintech Europe), -DIS3L (1:2000; HPA041805
Sigma-Aldrich), -GFP (1:2000; sc-9996; Santa Cruz)
and -GAPDH (1:5000, NB300-327; Novus Biologicals)
antibodies. Primary antibodies were detected with goat
-rabbit or -mouse secondary antibodies (Calbiochem)
conjugated with horseradish peroxidase and visualized
using an Immun-Star WesternC Chemiluminescence Kit
(Bio-Rad) according to the manufacturer’s protocol. Sig-
nals from ECL substrates were detected and documented
using X-ray film (developed with AGFA CP1000) or by
the charge-coupled device camera in the FluorChem SP
Superior Performance Imaging System (Alpha Innotech).
Oligonucleotides
Oligonucleotides used in cloning, site-directed mutagenesis,
qPCR and Northern blotting are listed in Supplementary
Tables S1, S2, S3 and S4, respectively.
Northern blot analysis
Total RNA was extracted using the standard TRI Reagent
protocol (Sigma-Aldrich), according to manufacturer’s in-
structions. RNA (13 g) was separated by electrophoresis
on a 1% denaturing formaldehyde-agarose gel. RNA was
then transferred onto Hybond N+ (GE Healthcare) mem-
branes by overnight capillary transfer in 20x SSC solution (3
MNaCl, 0.3 M sodium citrate) and fixed on the membrane
by UV cross-linking at 254 nm. Hybridization procedures
were carried out in PerfectHyb Plus hybridization buffer
(Sigma-Aldrich). The blots were hybridized overnight at
63◦C with respective PCR-based probes (see Supplemen-
tary Table S4 for primers used for amplifications with hu-
man cDNAas a template), labeled by random-priming with
[-32P]dATP and a DecaLabel DNALabeling Kit (Thermo
Scientific) according to the manufacturer’s instructions. Af-
ter hybridization, membranes were washed twice with 2x
SSC, 0.1% SDS at 63◦C for 45 min and exposed to a Phos-
phorimager screen (FujiFilm), which was then scanned us-
ing a FLA7000 scanner (FujiFilm). Between hybridizations,
probes were stripped off the membranes at 65◦C using boil-
ing 0.1% SDS (two washes, 45 min each).
RESULTS
A short isoform of HBS1L interacts with the exosome com-
plex
To identify proteins interacting with the cytoplasmic form
of the exosome, Co-IP experiments were performed us-
ing stable HEK293 cell lines producing an EGFP-tagged
DIS3L protein or RRP4 exosome core subunit (Figure 1A
and B, Supplementary Figure S2). In addition to high-
salt conditions that enabled reductions in background sig-
nals, we conducted Co-IPs from cells treated with the cell-
permeable cross-linker dithiobis[succinimidyl propionate]
(DSP), to increase the likelihood of detecting weak, tran-
sient interactions. The enriched proteins were then iden-
tified by high-resolution MS and analyzed by LFQ using
MaxQuant software (40,41) (Figure 1A and B; Supple-
mentary Figures S1; S2; Data set S1). As expected, using
DIS3L-EGFP as bait we recovered high amounts of all exo-
some core components, whereas the amount of the nucleus-
specific subunits DIS3 and EXOSC10 was not significant.
For RRP4-EGFP Co-IP assays carried out in parallel, we
observed 2–3 orders of magnitude higher levels of nucleus-
specific components. Importantly, all subunits of the SKI
complex were detected in DIS3L-EGFP cross-linked sam-
ples, although the amount of the smallest one,WDR61, was
relatively low, because of which it was discarded by the LFQ
algorithm. This indicates that the human exosome indeed
physically interacts with the SKI complex. Interestingly, we
also identified the HBS1L protein in the DIS3L-EGFP and
RRP4-EGFP Co-IP experiments. Closer inspection of the
peptides revealed that for the DIS3L-EGFPCo-IP, only the
N-terminal fragment of the canonical HBS1L (HBS1LV1)
was represented in theMS spectrum. A previous study indi-
cated that HBS1L pre-mRNA may be alternatively spliced
(42). Indeed, we observed several peptides that mapped to
the putative protein encoded by the short splicing isoformof
the HBS1L, which we will hereafter refer to as HBS1LV3.
Analysis of cDNA clones and RNA-seq data revealed that,
apart from the canonical variant, additional transcripts
that potentially coded for HBS1LV3 indeed existed in hu-
man cells (Figure 2). In contrast, a putative HBS1LV2
mRNA, which is annotated in databases, was undetectable
in HEK293 cells using RT-PCR. To further confirm the ex-
istence of HBS1LV3, we attempted to raise specific anti-
bodies that recognized HBS1LV3, but were unable to ob-
tain antibodies with sufficient specificity for this isoform.
However, commercial antibodies raised against a fragment
located within the N-terminal region that is common to
both HBS1LV1 and HBS1LV3 produced two bands on a
Western blot. siRNA-mediated silencing in HEK293 cell
lines confirmed that the main, upper band corresponded
to the canonical HBS1LV1 variant while the less intense,
lower band was consistent with the HBS1LV3 variant (Fig-
ure 1C).
The DIS3L Co-IP-MS experiments recovered not only
the SKI complex and the exosome but also many other
putative interactors (Supplementary Figure S2; Data set
S1). However, the majority of these other proteins was
highly sub-stoichiometric or had relatively low specificity.
Although we cannot exclude the possibility that the cyto-
plasmic exosome and/or the SKI complex have other func-
tionally relevant interacting partners, their analysis is out-
side the scope of this study.
Together, our analyses revealed that the human cytoplas-
mic exosome interacts with the HBS1LV3, a protein en-
coded by the short splicing variant of HBS1L. Thus, like
Ski7 in yeast, in humans HBS1LV3 likely links the human
exosome with the SKI complex.
 at A
BE M
arketing on January 9, 2017
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
6 Nucleic Acids Research, 2016
HBS1L
transcripts
HBS1LV3
Scale
chr6: 135 036 500 135 039 5001 kb hg38 UCSC Genes
RNAseq spliced reads
RNA-seq
0
-0.4
RNA-seq
reads
HBS1LV3
1 kb hg38134 980 000 135 050 000UCSC Genes
Scale
chr6:
HBS1L
putative
transcripts
0
-0.899284
chr6 (q32.3)
A
B
C
HEK293
RNA-seq
HEK293
HBS1LV1
HBS1LV2
12345'
123457 68
9
12 131415161718  
11 
10 
Figure 2. Transcript variant coding for putative HBS1LV3 protein is present in human HEK293 cells. Illustrative screen shots from the University of
California Santa Cruz (UCSC) Genome Browser. Exons are shown as blue rectangles and numbered in red. HBS1LV1 mRNA consists of 18 exons,
HBS1LV2 mRNA lacks the third exon and HBS1LV3 mRNA contains an alternative fifth exon (designated as 5′). Introns are shown as lines connecting
exons. Arrowheads indicate the direction of transcription. Mapped reads are shown as grey peaks. (A) Chromosomal localization of theHBS1L gene. (B)
The UCSC Genes track of gene predictions. (C) Zoomed-in view of the junction between exon 4 and alternative exon 5. The junction was confirmed by
overlapping RNA-seq reads.
HBS1LV3 links the exosome with the SKI complex
The yeast Ski7 is a multi-domain protein. The N-terminal
fragment of Ski7 participates in interactions with both the
exosome and the SKI complex (23). The C-terminal region
of Ski7 shares similarities with the eRF3 (eukaryotic release
factor 3) protein, and consists of 3 domains: a GTP-binding
domain that recognizes an empty A site in ribosomes dur-
ing non-stop decay, followed by two beta barrels (43,44).
Interestingly, the C-terminal domain Ski7 shares similar-
ity with the yeast Hbs1 protein (Figure 1D). HBS1LV3 in
humans has an N-terminal region that is identical to the
canonical HBS1LV1 variant and shares sequence similarity
with the yeast Ski7 (Figure 1D). In contrast, the HBS1LV3
C-terminal part displays no similarity to any known pro-
tein, apart from its orthologues in other vertebrate species
(Supplementary Figure S4). Although in silico predictions
revealed the presence of some secondary structure features
in the HBS1LV3 C-terminal part (Supplementary Figure
S5), making reliable predictions of the structure in this part
of the protein was difficult.
In order to further characterize HBS1LV3 and
HBS1LV1, the respective cDNAs were cloned and
stable cell lines producing EGFP-tagged proteins were
constructed. In parallel with HBS1LV1 and HBS1LV3,
a cell line producing EGFP-tagged SKI2W was similarly
generated to serve as a control for subsequent experiments.
Importantly, confocal imaging revealed that EGFP-tagged
HBS1LV3 localized to the cytoplasm in human HEK293
cells, which is in agreement with its co-purification with
DIS3L (Figure 3).
Subsequent Co-IP-MS experiments revealed that the
newly discovered HBS1LV3 protein specifically interacts
with the cytoplasmic exosome complex, since, in addition
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Figure 3. EGFP-tagged HBS1LV3, HBS1LV1 and SKI2W proteins local-
ized to the cytoplasm. Fluorescence imaging of stable HEK293 cell lines
expressing EGFP-tagged HBS1LV3, HBS1LV1 or SKI2W proteins. Nu-
clei were stained with Hoechst. Scale bars represent 10 m.
to the exosome core subunits, we identified the exclusively
cytoplasmic DIS3L exoribonuclease but not its nuclear par-
alogue, the DIS3 protein, which localizes mainly in the nu-
cleoplasm of human cells (Figure 1E and F, Supplemen-
tary Figure S2). Finally, SKI complex components also co-
purified with HBS1LV3. Meanwhile, canonical HBS1LV1
did not seem to interact with the exosome, but did co-purify
with the SKI complex (Figure 1E and F, Supplementary
Figure S2). This result indicated that the N-terminal frag-
ment shared by both analyzed HBS1L isoforms is responsi-
ble for interactions with the SKI complex but not with the
exosome. Importantly, the well-known HBS1LV1 binding
partner and Dom34 homologue, the PELOTA protein, did
not co-purify with HBS1LV3 (Figure 1E and F; Supple-
mentary Figure S2), suggesting that the two HBS1L vari-
ants play different roles. Finally, MS analyses showed that
SKI2Wco-purifiedwith all predicted SKI complex subunits
as well as HBS1LV3 and the exosome (Data set S1).
In order to verify if HBS1LV3, like Ski7 in yeast, bridges
the exosome with the SKI complex in humans, we per-
formed co-sedimentation experiments using extracts from
control cells and cells depleted of HBS1LV3 or HBS1LV1.
The extracts were separated in linear glycerol gradient, fol-
lowed by Western blot detection of SKI2W, DIS3L and
HBS1L (Figure 4 and Supplementary Figure S3, where
the second biological replica is shown). First of all, it is
clearly visible that gross amounts of SKI2W andDIS3Lmi-
grate as separate assemblies with peaks at fractions 6–8 for
SKI2W and 8–10 for DIS3L, which is in agreement with the
transient nature of the SKI/exosome supercomplex forma-
tion. However, they are also partially migrating as higher
molecular weight species (lanes 9–13). Importantly, deple-
Figure 4. Density-based separation of protein complexes by glycerol gradi-
ent centrifugation. (A) Protein–protein complexes were separated by glyc-
erol gradient centrifugation. Precipitated proteins were then resolved in
SDS-PAGE and analyzed by Western blotting. -SKI2W, -DIS3L and
-HBS1L antibodies were used. (B) SKI2W and DIS3L band intensities
are shown as a line graph.
tion of HBS1LV3 strongly reduces that fraction (Figure
4; compare upper and bottom panels). Interestingly, upon
HBS1LV1 depletion, there is an opposite effect, i.e. more
DIS3L and SKI2W migrate as larger assemblies (Figure 4;
compare upper and middle panels). This is probably be-
cause HBS1LV1 competes with HBS1LV3 for interactions
with the SKI complex, thus inhibiting exosome complex as-
sociation with the SKI. Finally, HBS1LV3 (which unfortu-
 at A
BE M
arketing on January 9, 2017
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
8 Nucleic Acids Research, 2016
nately is well-visible only in HBS1LV1 depleted samples)
co-migrates with DIS3L, enriching toward higher molecu-
lar weight species. Altogether, these data strongly suggest
that HBS1LV3 indeed bridges SKI complex with the exo-
some, since HBS1LV3 levels determine the efficiency of the
SKI/exosome supercomplex formation.
The unique C-terminal region of HBS1LV3 binds to the exo-
some core
The exosome-interacting fragments in the HBS1LV3 vari-
ant likely reside within its unique C-terminal region. In
order to determine the approximate location of exosome-
binding motifs within HBS1LV3, we carried out Co-IP ex-
periments with EGFP-tagged, C-terminally truncated pro-
teins. We observed that full-length and minimally truncated
proteins (HBS1LV3, HBS1LV31-602 and HBS1LV31-572) co-
purified with both RRP40 (exosome core protein) and the
SKI2W helicase (Figure 5A and B). Meanwhile, longer
truncations (HBS1LV31-546 and HBS1LV31-516) substan-
tially weakened interaction with the exosome RRP40 pro-
tein (Figure 5A and B), indicating that HBS1LV3 residues
that participate in interactions with the exosome complex
are located downstream of position 546. Interestingly, this
region is also the most conserved one (Supplementary Fig-
ure S4), and contains a previously identified motif PFD-
FxxxSPDDIVKxNQ (aa 609–625) (42).
To further characterize the exosome-interacting motifs,
we divided the extreme C-terminal amino acids (aa 546–
632) of the HBS1LV3 protein into three fragments referred
to as: Fragment 1 (aa 546–572), 2 (aa 572–602) and 3 (aa
602–632). Co-IP experiments using EGFP-tagged single (1
and 3) and fused (1+2, 1+2+3, 1+3 and 2+3) fragments
were then conducted (Figure 5A and C). We demonstrated
that the core exosome interacts with an increasing efficiency,
as evidenced by anti-RRP40 Western blot detection, with
constructs comprising Fragments 1, 1+2 and 1+2+3, re-
spectively. The interaction is weaker for Fragments 1+3 and
there were no interactions seen with Fragments 3 and 2+3
(Figure 5A and C). In addition, these fragments do not
contribute to the HBS1LV3/SKI interactions, which is con-
sistent with previous observations. Thus, we conclude that
Fragment 1 (aa 546–572) is crucial and sufficient to medi-
ate interactions with the exosome, while other regions of
the HBS1LV3 C-terminus, including the PFDFxxxSPDDI-
VKxNQ motif, play a minor role in the interaction.
The HBS1LV3 peptide docks into the RRP43 exosome ring
subunit
We next analyzed the amino acid sequence of the HBS1LV3
exosome-interacting fragment (aa 546–572), and found that
these residues may adopt an alpha-helical conformation
(Figure 6A, Supplementary Figures S4 and S5), which al-
lowed us to model its structure based on an ideal helix con-
formation.
We used the previously determined structure of the hu-
man exosome ring (PDB ID: 2NN6) (39) and performed
automatic docking of HBS1LV3 exosome-interacting frag-
ment using the ZDOCK server (37) (Figure 6A, Supple-
mentary Figure S6). Strikingly, 5 out of the 10 best pre-
dictions docked into the surface of the RRP43 exosome
A
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Figure 5. The HBS1LV3 C-terminus interacts with the cytoplasmic ex-
osome complex. (A) Schematic representation of the HBS1LV3 protein.
The N-terminal domain and the C-terminus of HBS1LV3 are colored grey
and yellow, respectively. Positions of protein truncations are indicated.
Locations of Fragments 1, 2 and 3 used for Co-IP experiments are de-
picted by red numbers. Total cell extracts were prepared using HEK293
cells transiently transfected with vectors bearing EGFP-tagged full-length
HBS1LV3 and (B) truncated HBS1LV3 proteins or (C) fragments of the
HBS1LV3 C-terminus. Co-IPs were performed using GFP trap resin. Both
the complete cell extracts (INPUT) and precipitated proteins (IP) were
separated by SDS-PAGE and analyzed by Western blotting. -EGFP, -
RRP40 and -SKI2W antibodies were used to visualize precipitated pro-
teins with -GAPDH antibodies serving as a loading control. The dashed
lines in (B) indicate that the gel was cropped. The upper part of blots in
(C) was overexposed due to the weak chemiluminescence signal.
core subunit in exactly the same position as where the
DIRIRAGNFKSALANLE peptide of yeast Rrp6 maps
into yeast Rrp43 (Figure 6A and B) (9,38). In contrast, Ski7
residues located in proximity of the abovementioned Rrp43
surface are mainly disordered and do not make contacts
with Rrp43 (23).
The critical residues of the yeast Rrp6 peptide
DIRIRAGNFKSALANLE involved in the interac-
tion with Rrp43 are R602, F606 and L610 (Figure 6B,
Supplementary Figure S6D) (9,38). Remarkably, the
HBS1LV3 fragment (aa 546–572) contains a conserved
RxxxFxxxL motif in which the R559, F563 and L567
residues are spaced similarly to yeast Rrp6 (Supplementary
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Figure 6. Model of HBS1LV3-exosome interactions. HBS1LV3 helix (aa
555–576) docks into the surface of RRP43. (A)Modeled humanHBS1LV3
helices docked into the exosome core (PDB code: 2NN6, (39)) are shown in
blue. The RRP43 protein is shown in green. The remainder of the human
exosome complex is colored grey. The 10 best predictions are shown, with 5
predictions docking into the same position on the surface of theRRP43 ex-
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ondary structure prediction of HBS1LV3 fragment. (B) A magnified view
of interactions. (C) R559, F563 and L567 HBS1LV3 amino acids are cru-
cial for interactions with the exosome complex. Total cell extracts were pre-
pared from HEK293 cells transiently transfected with vectors expressing
either EGFP-taggedHBS1LV3 (WT) orHBS1LV3MUT (R559A, F563A,
L567A) proteins. Co-IPs were performed using GFP trap resin. The com-
plete cell extracts (INPUT) and precipitated proteins (IP) were separated
by SDS-PAGE and analyzed by Western blotting. -HBS1L, -RRP40
and -SKI2W antibodies were used to visualize precipitated proteins. -
GAPDH antibodies were utilized as a loading control.
Figure S6F). However, the predicted helical region of
HBS1LV3 could be smaller than that of yeast Rrp6 due
to the presence of two prolines at positions 560 and 572.
The first proline is after a conserved arginine (R559),
so this arginine is likely to be located just outside the
helix. In the crystal structure of the yeast Rrp6/exosome
complex, this conserved arginine (R559) makes contacts
with main chain atoms as well as with the side chain of
glutamic acid (E48), which is conserved in the human
exosome (E31) (Supplementary Figure S6). In yeast Rrp6,
phenylalanine 606 (F606, equivalent to F563 in HBS1LV3)
is part of a stacking interaction with an Rrp43 histidine
(H34). In human RRP43 this histidine is substituted with
a phenylalanine (F17) that can also engage in a stacking
interaction (Figure 6A and B; Supplementary Figure S6).
Strikingly, a model of the HBS1LV3 C-terminal peptide
further optimized by homology modeling, docked into
the human exosome structure, fits well with the corre-
sponding binding site in human RRP43. In particular,
the R559 and F563 residues of HBS1LV3 that are crucial
for HBS1LV3/exosome interactions docked well into the
RRP43 binding site (Figure 6A and B). Furthermore, there
is an additional aromatic residue tyrosine (Y13) in the
human RRP43 exosome subunit that is located near the
conserved F17 in such a way that the helix’s phenylalanine
(F563) is located between the human RRP43 F17 and Y13
residues, thus this tyrosine can also take part in a stacking
interaction (Figure 6A and B). In the case of the yeast,
conserved leucine (L610) of Rrp6 makes contact with the
side-chain of a Rrp43 threonine (T16) (Supplementary Fig-
ure S6C). This amino acid is also present in the HBS1LV3
RxxxFxxxL motif (L567). Although the precise role of this
amino acid in the exosome/HBS1LV3 linkage is difficult
to predict, because T16 is not conserved, the interaction
could involve hydrophobic contacts.
To provide experimental support for our model, we per-
formed site directed mutagenesis to substitute alanines
at crucial residues in the HBS1LV3 C-terminal peptide
(R559A, F563A, L567A; HBS1LV3 MUT). Mutation of
these residues largely abolished interactions of HBS1LV3
with the exosome (Figure 6C). Thus, the identified peptide
and its crucial amino acids are both essential and sufficient
for HBS1LV3/exosome interactions.
The HBS1LV3 protein participates in the cytoplasmic
exosome-dependent mRNA decay pathway
To identify transcripts that are degraded by cytoplasmic
SKI/HBS1LV3/exosome supercomplexes, we used specific
siRNAs to knock down expression of genes coding for
HBS1L proteins and SKI2W helicase in HEK293 cells. In
order to reduce the risk of possible siRNA off-target ef-
fects, parallel rescue experiments were performed in which
cell lines exogenously producing siRNA-insensitive protein
variants were treated with respective siRNAs. Slight over-
expression of exogenous proteins compared to the endoge-
nous proteins’ levels was observed (Supplementary Figure
S7). qPCR-based mRNA quantification in siRNA-treated
cells showed a 50–91% decrease in siRNA-targeted tran-
script levels (Supplementary Figure S8A–C). Moreover,
these results were validated at the protein level by Western
blot analysis (Supplementary Figure S8D), which demon-
strated that even relatively modest decreases in transcript
levels resulted in a strong decrease in the protein amounts.
Total ribo-depleted RNA-seq libraries were prepared from
all cell lines treated with siRNAs in triplicate. On average,
13.9 million reads were uniquely mapped to the genome for
each library.
To identify genes with altered expression, we compared
the effect of siRNA silencing of HBS1LV1, HBS1LV3
or SKIV2L with respective rescue cell lines treated with
the same siRNAs. Differential expression analysis revealed
varying degrees of influence of siRNA-mediated protein
depletion on steady-state levels of known transcripts. Im-
portantly, depletion of HBS1LV3 had the strongest effect
on the transcriptome with 2142 genes (11 301 transcripts)
deregulated by more than 1.5-fold, whereas depletion of
SKI2W altered expression of 608 genes (4135 transcripts).
Depletion of canonical HBS1LV1 had the weakest effect on
gene expression, giving only 199 statistically significant hits
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(1483 transcripts) (Figure 7A–C), despite the fact that de-
pletion of both mRNA and protein appeared to be equal or
even more efficient for HBS1LV1 than for HBS1LV3 and
SKIV2L (Supplementary Figure S8).
Direct mRNA substrates of the cytoplasmic exosome
would be expected to be stabilized when the components
of this complex are depleted, and indeed more genes were
upregulated than downregulated in the presence of specific
siRNAs (1387 for HBS1LV3, 508 for SKIV2L and 145 for
HBS1LV1). We then looked at the overlap of these hits to
assess the functional intersection of the analyzed proteins.
A more pronounced intersection between HBS1LV3 and
SKIV2L (54% of the SKIV2L set and 20% of theHBS1LV3
set were common) occurred relative to canonicalHBS1LV1
with the other sets (8–10% SKIV2L-HBS1LV1 common
hits and 10–15%HBS1LV3-HBS1LV1 common hits) (Fig-
ure 7D). Because the overlap of considerably different-sized
sets (over 8-fold different) may be confusing to interpret, we
also compared sets of fixed sizes that contained the most
significantly deregulated genes rather than choosing an ab-
solute significance threshold. For the top 200 most signif-
icantly upregulated genes, there were twice as many com-
mon targets for HBS1LV3 compared to SKI2W than for
HBS1LV1 compared to SKI2W or to HBS1LV3.
Together, our data demonstrated that the lack of the
HBS1LV3 or the SKI2W protein resulted in similar global
effects, which strongly suggests their involvement in the
same mRNA degradation pathway. However, since the ef-
fect of HBS1LV3 depletion was overall stronger than that
of SKI2W, we cannot exclude that HBS1LV3 has a SKI
complex-independent role in RNA decay. Finally, the func-
tion of HBS1LV1 in transcriptome homeostasis appears to
be less important.
The HBS1LV3 protein enables proper cytoplasmic mRNA
decay
Data obtained from high-throughput experiments were fur-
ther validated by qPCR (Supplementary Figure S9). The
transcripts most significantly affected by HBS1LV3 down-
regulation (NOSIP, TRAPPC2L splicing variant and TN-
FRSF12A) were selected and tested. We demonstrated that
levels of the selected transcripts increased on average 2- to
2.5-fold in theHBS1LV3 isoform knockdown compared to
control samples. Rescue experiments conducted simultane-
ously restored the wild-type phenotype, thereby confirming
the previously obtained results.
To verify whether the observed upregulation of mRNA
levels inHBS1LV3-depleted cells resulted from inhibition of
mRNA decay, we measured the half-lives of selected tran-
scripts by experiments using actinomycinD treatment to in-
hibit transcription. As in the previous experiments, we de-
pleted proteins of interest using RNAi and then assessed
NOSIP, TRAPPC2L splicing variant, TNFRSF12A and
mitochondrial ATP6/8 (negative control) transcript levels
following 0, 2, 4 and 6 h of transcription inhibition by 4
g/ml of actinomycin D. All three tested mRNAs were sta-
bilized in HBS1LV3-depleted cells with half-lives up to 5.5-
fold longer than in control cells (Figure 7E; Supplementary
Figure S10). SKI2W depletion resulted in stabilization of
NOSIP andTNFRSF12AmRNAs, with up to 2-fold higher
half-lives, but not of the alternative TRAPPCL2 mRNA.
ATP6/8 remained largely unchanged in both cases. These
results were further confirmed by Northern blot analysis
(Figure 7F).
Together, these data strongly suggest that the inhibition
of cytoplasmic mRNA decay occurs upon downregulation
of HBS1LV3 or SKIV2L. Gene ontology analysis of tran-
scripts upregulated following HBS1LV3 depletion did not
identify any particular cellular process as being more signif-
icantly affected, suggesting that HBS1LV3 plays a general
rather than specific role in cytoplasmic exosome-mediated
mRNA decay.
DISCUSSION
The structure-function relationship of Hbs1 and Ski7
proteins deserves an evolutionary consideration. Saccha-
romyces species have two separate genes, probably as a con-
sequence of a genome duplication event, one encodingHbs1
and the other Ski7 (42). Both proteins have a C-terminal
eRF3-like domain (Figure 1D), postulated to interact with
the ribosome A site and important to translation-based
quality control pathways (29). Due to sequence differences,
the longer N-terminal region of Ski7 can bind the exosome
and SKI while the C-terminal domain of Hbs1 interacts
with Dom34, another factor involved in releasing stalled ri-
bosomes. However, in other fungi alternative mRNA splic-
ing of a single HBS1/SKI7 gene gives rise to two proteins
that differ in their N-terminal region and only the longer
one can bind the exosome and SKI complex; the short form
is thought to perform Hbs1 functions and the long one
– Ski7 functions (42,45). In these species the C-terminal
eRF3-like domain is identical in both proteins (22,42) and
thus presumably both can interact with Dom34. A sim-
ilar phenomenon may occur in plants, where the HBS1
seems to be alternatively spliced and previous studies sug-
gested that one of the gene’s products may have Ski7-like
properties (42). Here, we show an analogous situation in
humans, where the HBS1L mRNA undergoes alternative
splicing to yield two proteins. The canonical Hbs1-like pro-
tein HBS1LV1 can interacts with SKI and PELOTA (hu-
man homolog ofDom34) (Figure 1E andF; Supplementary
Figure S2) (29). The newly discovered Ski7-like HBS1LV3
has the same N-terminal region, facilitating interaction
with SKI, but the eRF3-like domain is replaced by a unique
C-terminal region that binds to the exosome. Notably, this
arrangement is specific to vertebrates (Supplementary Fig-
ure S4) as the HBS1LV3 protein seems to be absent from all
other metazoans and the nature of the SKI-exosome inter-
action in those animals remains unknown.
In yeast, Ski7 is a stable component of the cytoplasmic
exosome, while its interactions with the SKI complex are
more transient (46). In this study, quantification of the Co-
IP-MS experiments as well as the fact that cross-linking was
essential for efficient SKI complex recovery in the cytoplas-
mic exosome pull-down assays strongly suggested that, like
yeast Ski7, human HBS1LV3 is more strongly associated
with the exosome core than the SKI. Although the exact
molecular mechanism of cooperation between the exosome
and the SKI complex in humans awaits further charac-
terization, the molecular modeling experiments supported
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(E) Relative mRNA level (y-axis) of NOSIP mRNA was measured by Real-Time qPCR following 0, 2, 4 and 6 h actinomycin D treatment. GAPDH
mRNA was used for normalization. Error bar represents SEM (five biological replicates). (F) Dashed lines represent exponential decay fits. Northern blot
analysis was performed using RNA from actinomycin D-treated cells, with DNA probes complementary to NOSIP, GAPDH and mitochondrial ATP6/8
transcripts (negative control).
by mutagenesis that we presented in this study support
an association between HBS1LV3 and the exosome core
that is mediated by the RxxxFxxxL motif located between
residues 559 and 567 ofHBS1LV3. This interaction between
HBS1LV3 and the RRP43 ring subunit resembles Rrp6
binding to the exosome core in S. cerevisiae. Another con-
servedmotif with the sequence PFDFxxxSPDDIVKxNQ is
located at the extreme C-terminus of human HBS1LV3 (aa
609–625) (42). Although the function of this motif is un-
clear, our data showed that these residues play a minor role
in HBS1LV3/exosome interactions. Since the RxxxFxxxL
motif identified in HBS1LV3 lies in a region that the yeast
Ski7 protein lacks, the interaction of Ski7with the yeast exo-
some core likely differs from that of theHBS1LV3/exosome
interaction in humans. Indeed, a recently published struc-
ture of yeast Ski7/exosome complex revealed that Ski7 does
not bind the Rrp43 region predicted by our homologymod-
eling to be responsible for HBS1LV3 helix recognition (23)
pointing to a similar but distinct mode of binding that is
utilized by HBS1LV3. This difference would be another ex-
ample of the rapid evolution of protein–protein interaction
motifs between different species, with a preservation of a
general interaction network that is quite common for pro-
teins involved in RNA decay (47).
The eRF3-like domain of yeast Ski7 is not essential
for exosome-mediated 3′-5′ decay, but is important for
other RNA quality control pathways such as no-go de-
cay, and is postulated to interact with the ribosomal A-
site (29). The human Ski7-like protein HBS1LV3 lacks
an eRF3-like domain, suggesting that HBS1LV3 may not
directly participate in translation-dependent surveillance
pathways. Indeed, we could not detect overrepresentation
of mRNAs that are predicted to be subject to such qual-
ity control pathways among the genes that were upregu-
lated upon HBS1LV3 depletion. Thus, our transcriptomic
analysis strongly suggests that HBS1LV3 is mainly involved
in bulk mRNA turnover, although it is highly probable
that in HEK293 cells XRN1-mediated 5′-3′ degradation or
DIS3L2-mediated 3′-5′ decay also play an important role in
shaping the global transcriptomic landscape (1).
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Although the canonical human HBS1LV1 does not bind
to the exosome, it can still interact with the SKI complex,
which is not the case for yeast Hbs1. Thus, HBS1LV1 can
compete with HBS1LV3 for SKI complex and thus inhibit
SKI/exosome supercomplex formation, although the ex-
act role of HBS1LV1/SKI association remains to be deter-
mined. The relatively small effect of HBS1LV1 depletion
on the steady-state mRNA levels suggests, however, that
this protein does not play an important role in the decay of
normal mRNA. Consistent with this possibility, canonical
HBS1LV1 in humans was recently proposed to be involved
in a quality control mechanism (e.g. non-stop mRNA de-
cay) in mammalian cells (29).
In HEK293 cells, the HBS1LV3 protein is produced at
much lower levels than the canonical variant HBS1LV1
(Figure 1C, Supplementary Figure S8D). In contrast to
HEK293 cells, available data show that high amounts of
HBS1LV3 expression occur in chronic myeloid leukemia
cell lines and in bonemarrow (www.proteinatlas.org), which
suggests that the SKI/HBS1LV3/exosome supercomplex
may play a primary role in mRNA decay in hematopoi-
etic cells. These conjectures are consistent with the fact
that exosome-dependent RNA decay involving the cyto-
plasmic exoribonuclease DIS3L controls primary erythroid
cell maturation (48).
In conclusion, here we have identified HBS1LV3, an ana-
logue of the yeast Ski7 protein, which is a long-sought linker
between the human cytoplasmic exosome and the SKI com-
plex, and in vertebrates is encoded by a specific splicing iso-
form of the HBS1L surveillance factor. The identification
of HBS1LV3 provides new insights into exosome-mediated
mRNA decay in humans.
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